HCV
The Hepatitis C Virus (HCV)is a blood-borne virus that was previously referred to as non-A/ non-B hepatitis. HCV has six major genotypes, numbered 1–6. Genotype 1, which is the most common in the U.S., is the most difficult to treat. HCV enters the body through direct blood exposure. The virus attacks cells in the liver, where it multiplies (replicates). HCV causes liver inflammation and kills liver cells. Up to 80% of people initially infected with HCV may become chronically infected—that is, the infection does not clear up within six months. Most people with chronic HCV do not have symptoms and lead normal lives. However, in 10–25% of people with chronic HCV, the disease progresses over a period of 10–40 years, and may lead to serious liver damage, cirrhosis (scarring), and liver cancer. Today, HCV is the leading reason for liver transplants in the U.S. There is currently no vaccine or cure for HCV, but various treatments can eradicate the virus and/or help slow or stop disease progression for some people.
